• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Aveanna Healthcare Holdings Announces CEO Transition and Reaffirms FY 2022 Revenue and Adjusted EBITDA Guidance

    12/13/22 5:07:50 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email

    ATLANTA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that its Chief Executive Officer and Director, Tony Strange, is retiring and will depart the company effective December 31, 2022. Jeff S. Shaner, Aveanna's long serving Chief Operations Officer, will serve as CEO and Director, effective December 31, 2022.

    "Tony's leadership was a significant part of Aveanna's formation and growth since its inception five years ago. He leaves an enduring legacy of building one of the nation's largest home care companies in America, during an unprecedented pandemic. Tony's steady and stable leadership was a welcome gift during troubled waters within our industry. It has been an honor working side-by-side, with Tony, at Aveanna and the many other companies during our career together. The Board and I are confident that under Jeff's leadership, Aveanna will continue its transition into a new era of value-based care. Jeff's experience, passion, and innovative mindset will serve Aveanna well as we look to the future," said Rod Windley, Chairman of Aveanna.

    "I am looking forward to this new leadership role as CEO and further building on the rock-solid commitment we have to clinical excellence and value creation here at Aveanna. Aveanna will continue with its mission making a positive impact in the lives of the patients and families that we serve every day," said Mr. Shaner.

    Mr. Strange commented, "I am looking forward to slowing down and assisting Jeff with his transition. I have worked with Jeff for over 20 years both at Aveanna and other industry leading home-health companies. Jeff is ready to lead Aveanna into a new era of growth, innovation, and clinical value creation. I am thankful to all the Aveanna employees for the opportunity to have served as your CEO."

    Aveanna also is reaffirming its most recent revised Full Year 2022 Guidance of (1) Revenue of at least $1,782 million and (2) Adjusted EBITDA of at least $128 million.

    Forward-Looking Statements

    Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements (other than statements of historical facts) in this press release regarding our prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward-looking statements. Forward-looking statements generally can be identified by the use of terminology such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "seek," "will," "may," "should," "predict," "project," "potential," "continue" or the negatives of these terms or variations of them or similar expressions. These statements are based on certain assumptions that we have made in light of our experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, such as our CEO and Director transition, our ability to successfully execute our growth strategy, including through organic growth and the completion of acquisitions, effective integration of the companies we acquire, unexpected costs of acquisitions and dispositions, the possibility that expected cost synergies may not materialize as expected, the failure of Aveanna or the companies we acquire to perform as expected, estimation inaccuracies in revenue recognition, our ability to drive margin leverage through lower costs, unexpected increases in SG&A and other expenses, changes in reimbursement, changes in government regulations, changes in Aveanna's relationships with referral sources, increased competition for Aveanna's services or wage inflation, changes in the interpretation of government regulations or discretionary determinations made by government officials, uncertainties regarding the outcome of rate discussions with managed care organizations and our ability to effectively collect our cash from these organizations, our ability to effectively collect and submit data required under Electronic Visit Verification regulations, our ability to comply with the terms and conditions of the CMS Review Choice Demonstration program, our ability to effectively implement and transition to new electronic medical record systems or billing and collection systems, changes in tax rates, the impact of adverse weather, the impact to our business operations, reimbursements and patient population were the COVID-19 environment to worsen, and other risks set forth under the heading "Risk Factors" in Aveanna's Annual Report on Form 10-K for its 2021 fiscal year filed with the Securities and Exchange Commission on March 28, 2022, which is available at www.sec.gov. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may prove to be incorrect or imprecise. Accordingly, forward-looking statements included in this press release do not purport to be predictions of future events or circumstances, and actual results may differ materially from those expressed by forward-looking statements. All forward-looking statements speak only as of the date made, and Aveanna undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    About Aveanna Healthcare

    Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 33 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient's normal caregiver. The Company's services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.

    Investor Contact

    Dave Afshar

    Chief Financial Officer

    [email protected]  



    Primary Logo

    Get the next $AVAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    12/13/2023Neutral → Underweight
    JP Morgan
    11/30/2023$1.50Sell
    UBS
    5/12/2023Strong Buy → Mkt Perform
    Raymond James
    1/27/2023$2.00 → $1.00Neutral → Underperform
    Credit Suisse
    11/21/2022$7.00 → $3.00Outperform → Sector Perform
    RBC Capital Mkts
    11/17/2022$5.50 → $2.00Outperform → Neutral
    Credit Suisse
    7/22/2022$2.50Buy → Hold
    Jefferies
    7/5/2022Buy → Hold
    Truist
    More analyst ratings

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

      First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

      5/8/25 6:30:59 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna to Participate at the RBC 2025 Global Healthcare Conference

      ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. Management will host 1x1 investor meetings as well as a fireside chat at 11:30 a.m. Eastern Time on the same day, May 20, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is headquart

      4/29/25 7:30:32 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna to Participate at the Bank of America Securities 2025 Health Care Conference

      ATLANTA, April 22, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. Management will host 1x1 investor meetings as well as a presentation at 3:15 p.m. Pacific Time on the same day, May 14, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthc

      4/22/25 7:30:52 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

      SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      2/14/24 4:00:42 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

      SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      2/14/22 6:43:51 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Williams Robert M Jr sold $606,941 worth of shares (103,132 units at $5.89) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      5/16/25 3:54:02 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner J.H. Whitney Equity Partners Vii, Llc sold $542,540 worth of shares (92,189 units at $5.89) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      5/16/25 3:41:39 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner Vigano Paul R sold $606,941 worth of shares (103,132 units at $5.89) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      5/16/25 3:37:11 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $AVAH
    Leadership Updates

    Live Leadership Updates

    See more
    • Aveanna downgraded by JP Morgan

      JP Morgan downgraded Aveanna from Neutral to Underweight

      12/13/23 6:49:11 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • UBS initiated coverage on Aveanna with a new price target

      UBS initiated coverage of Aveanna with a rating of Sell and set a new price target of $1.50

      11/30/23 7:52:45 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna downgraded by Raymond James

      Raymond James downgraded Aveanna from Strong Buy to Mkt Perform

      5/12/23 7:24:50 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Appointment of New Director

      ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder

      11/4/24 7:30:02 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

      ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and

      4/3/24 6:30:06 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

      ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t

      12/11/23 7:30:00 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Financials

    Live finance-specific insights

    See more
    • Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

      First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

      5/8/25 6:30:59 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Announces First Quarter 2025 Earnings Release Date and Conference Call

      ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13752435. The replay will be available until May 15, 2025. Int

      4/17/25 6:30:46 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Outlook

      Fourth Quarter Revenue was $519.9 million, an 8.6% increase over the prior year period Gross margin increased 15.7% to $171.7 million compared to Q4 2023 Fourth Quarter Net income was $29.2 million compared to net loss of $25.7 million for the comparable prior year period Adjusted Net income was $11.1 million, an increase of $14.3 million compared to Q4 2023 Adjusted EBITDA for Q4 2024 was $55.2 million, a 42.8% increase as compared to Q4 2023Full Year 2025 Revenue guidance between $2.10 - $2.12 billion Full Year 2025 Adjusted EBITDA guidance between $190 - $194 million ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:A

      3/13/25 6:30:16 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    SEC Filings

    See more
    • SEC Form 144 filed by Aveanna Healthcare Holdings Inc.

      144 - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      5/12/25 5:23:25 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form 144 filed by Aveanna Healthcare Holdings Inc.

      144 - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      5/12/25 5:20:40 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form 144 filed by Aveanna Healthcare Holdings Inc.

      144 - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      5/12/25 5:17:07 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care